IGY Immune Technologies & Life Sciences (ITLS) acquired technology to isolate and purify egg based antibodies in purities from 10% to 95% pure.
Read MoreCommercial Applications
Our commercial applications fall across 4 primary sectors which means we can grow our product base and revenue streams against any cyclical variations.
Medicines
Includes Pharmaceuticals and Nutraceuticals.
Focus on royalty-based partnerships with major healthcare providers to provide solutions targeting specific pathegens.
Functional Foods
Partnerships with established consumer packaged food companies by supplying IgY as an immune enhancing ingredient.
Agriculture / Feeds
Partnerships with agribusinesses and meat product companies to provide solutions to lessen the use of antibiotics.
Cosmeceuticals
Focus on IgY-based bio-cosmetics through partnerships with major manufacturers and marketers and via private brands.
IGY Immune Technologies & Life Sciences (ITLS) acquired technology to isolate and purify egg based antibodies in purities from 10% to 95% pure.
Read MoreIgY Life Sciences announces the launch of the companies updated website. The website is prepared for the purpose of educating the public about the importance of IgY and what purpose it is used for.
Read More